The world’s largest vaccine maker will halve the production of its Covid-19 vaccine because it has no fresh orders, its top-ranking executive has said. India’s Serum Institute is sitting on a stockpile of half a billion doses of Covishield, the local version of AstraZeneca’s Vaxzevria jab, the firm’s CEO Adar Poonawalla told CNBC-TV18. The jab accounts for 90% of the 1.3 billion doses given so far in India. India has fully vaccinated half of its eligible adults since January. “I am in a dilemma which I never imagined to be in. I am producing 250 million doses [of Covishield] a month but the good news is India has covered a large part of the population and we will have completed all our orders to the ministry of health in a week’s time,” Mr Poonawalla said . “We have no other orders at hand. So I am going to be reducing the production by at least 50% to begin with on a monthly basis until orders again pick up either in India and the world.”(BBC)…[+]
-
SNELNIEUWS
-
11:21 am Golden State Warriors voor zesde keer in acht jaar naar NBA-finale
May 27, 2022 -
11:18 am Hamilton mag sieraden voorlopig toch blijven dragen tijdens GP-weekenden
May 27, 2022 -
11:16 am Ibrahimovic speelde maanden zonder kruisband omdat hij Milan titel had beloofd
May 27, 2022 -
11:13 am Zes jaar celstraf voor verkrachting elfjarige
May 27, 2022 -
11:12 am Verdachte inbraak Maystraat wil onderzoek ‘verklikkers’
May 27, 2022 -
11:10 am Rover wil geen SRD
May 27, 2022 -
10:43 am Badr Hari vecht op 8 oktober in GelreDome tegen GLORY-debutant Overeem
May 26, 2022 -
10:40 am Ook Britse regering keurt Amerikaanse overname van Chelsea goed
May 26, 2022
-
Nieuws Archief
Social media